Surmodics Inc (SRDX) Stock Price, Quote & News

Company Profile

Surmodics, Inc., together with its subsidiaries, provides performance coating technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates through two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deploy...

Industry: Medical Devices

Sector: Healthcare

Phone: 952 500 7000

Fax: 952 500 7001

Website: www.surmodics.com

Address:

9924 West 74th Street, Eden Prairie, United States

TwongStocks Nov. 18 at 7:16 PM

$SRDX NASDAQ Equity Corporate Actions Alert # 2025 - 616 Information Regarding the Merger of Surmodics, Inc. (SRDX) https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2025-616 At a special meeting held on August 13, 2024, the shareholders of Surmodics, Inc. (SRDX) approved a merger with BCE Parent, LLC, an affiliate of GTCR LLC. The merger is tentatively scheduled to close prior to the market open on November 19, 2025, subject to the completion of the closing. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on November 18, 2025. If the merger closes as anticipated, the stock will remain halted on the day of closing (November 19th) and will be suspended effective November 20, 2025. SRDX shareholders will receive $43.00 per share at closing.

0 · Reply

SweepCastApp Nov. 18 at 12:28 AM

$SRDX: Unusual Options Activity Alerted CALL flow observed 93x contracts at Strike price of $40 Exp on 11/21/2025 with Premium of $27K and showing BEARISH Sentiment

0 · Reply

AStrokeOfLuck Nov. 17 at 2:25 PM

$SRDX

0 · Reply

OpenOutcrier Nov. 17 at 1:22 PM

$SRDX (+3.0% pre) Surmodics expects to close GTCR acquisition after FTC drops appeal https://ooc.bz/l/84749

0 · Reply

PickAlpha Nov. 17 at 12:55 PM

2/3: Surmodics says FTC drops appeal of court loss, clearing path for $627M sale to GTCR $SRDX $IHI $XLV

0 · Reply

JarvisFlow Nov. 14 at 6:08 PM

Barrington Research updates rating for Surmodics ( $SRDX ) to Underperform.

0 · Reply

Fugazi_ Nov. 12 at 7:46 PM

$SRDX was this court decision planned to be announced the 10th or was it random?

1 · Reply

Estimize Nov. 12 at 11:00 AM

Wall St is expecting -0.13 EPS for $SRDX Q1 [Reporting 02/10 BMO] http://www.estimize.com/intro/srdx?chart=historical&metric_name=eps&utm_c

0 · Reply

basereport Nov. 12 at 2:12 AM

🚀 Strongest stocks of the day Start tracking these today using our free stock screener: https://base.report/screener?filter_key=IJQVaoxW $MSPR $SRDX $ENGN $PUBM

0 · Reply

jerrymaltz Nov. 12 at 1:32 AM

$CJJD $SRDX Bears are retreating, and bulls are pressing their advantage. https://stocktwits.com/jerrymaltz

0 · Reply

Surmodics Announces FTC Does Not Intend to Appeal Denial of Injunction, Order Preventing Closing Set to Expire Today

Nov 11, 2025, 12:00 PM EST - 4 weeks ago

Federal Judge Clears Path For GTCR's Takeover Of Surmodics After FTC Challenge

Nov 10, 2025, 7:00 PM EST - 4 weeks ago

Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

Nov 4, 2025, 6:15 AM EST - 5 weeks ago

Surmodics Announces Outcomes from 160 Patients in PROWL Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

Nov 3, 2025, 6:15 AM EST - 5 weeks ago

Surmodics Announces PROWL Registry 160-Patient Data to be Presented in Industry-Sponsored Session at VIVA Conference on November 3

Aug 8, 2025, 7:12 AM EDT - 4 months ago

Surmodics (SRDX) Q3 EPS Turns Positive

Aug 8, 2025, 7:00 AM EDT - 4 months ago

Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance

Aug 6, 2025, 4:05 PM EDT - 4 months ago

Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8

Apr 30, 2025, 7:00 AM EDT - 7 months ago

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance

Apr 28, 2025, 6:00 PM EDT - 8 months ago

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

Apr 22, 2025, 7:00 AM EDT - 8 months ago

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon

Apr 3, 2025, 7:00 AM EDT - 8 months ago

Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries

Mar 6, 2025, 9:00 PM EST - 9 months ago

Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR

Mar 6, 2025, 4:22 PM EST - 9 months ago

FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics

Feb 6, 2025, 7:01 AM EST - 10 months ago

Top 3 Health Care Stocks You'll Regret Missing This Month

DJT MRK

Feb 3, 2025, 7:00 AM EST - 11 months ago

Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries

Jan 30, 2025, 7:00 AM EST - 11 months ago

Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results

Nov 6, 2024, 7:00 AM EST - 1 year ago

Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Oct 30, 2024, 2:30 PM EDT - 1 year ago

Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results

Jul 17, 2024, 4:31 PM EDT - 1 year ago

SURMODICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX

Jun 10, 2024, 7:00 AM EDT - 1 year ago

Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.

May 30, 2024, 10:30 PM EDT - 1 year ago

SURMODICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Surmodics, Inc. - SRDX

May 29, 2024, 6:36 PM EDT - 1 year ago

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Surmodics, Inc.

May 29, 2024, 7:00 AM EDT - 1 year ago

Surmodics Enters into Definitive Agreement to be Acquired by GTCR for $43.00 Per Share in Cash, Representing an Approximate Equity Value of $627 Million

May 1, 2024, 4:07 PM EDT - 1 year ago

Surmodics, Inc. (SRDX) Q2 2024 Earnings Call Transcript

May 1, 2024, 7:00 AM EDT - 1 year ago

Surmodics Reports Second Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Apr 19, 2024, 7:00 AM EDT - 1 year ago

Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1

Feb 27, 2024, 8:00 AM EST - 1 year ago

Surmodics to Participate in Upcoming Investor Conferences in March and April

Feb 1, 2024, 2:41 PM EST - 2 years ago

Surmodics, Inc (SRDX) Q1 2024 Earnings Call Transcript

Feb 1, 2024, 7:00 AM EST - 2 years ago

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Jan 22, 2024, 7:30 AM EST - 2 years ago

Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee

Jan 16, 2024, 7:30 AM EST - 2 years ago

Surmodics to Host Virtual Annual Meeting of Shareholders

Jan 16, 2024, 7:30 AM EST - 2 years ago

Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1

Nov 16, 2023, 7:30 AM EST - 2 years ago

Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium

Nov 16, 2023, 7:30 AM EST - 2 years ago

Surmodics Announces TRANSCEND Trial 36-Month Data Presented at 50th Annual VEITH Symposium

Nov 14, 2023, 4:05 PM EST - 2 years ago

Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28

Nov 10, 2023, 10:06 AM EST - 2 years ago

Surmodics, Inc. (SRDX) Q4 2023 Earnings Call Transcript

Nov 8, 2023, 7:30 AM EST - 2 years ago

Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Financial Guidance

Nov 7, 2023, 7:30 AM EST - 2 years ago

Surmodics Announces SWING Trial 24-Month Data to be Presented at VEITH Symposium on November 15

Nov 7, 2023, 7:30 AM EST - 2 years ago

Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

Oct 31, 2023, 7:30 AM EDT - 2 years ago

Surmodics Announces Launch of Preside™ Medical Device Coating Technology, Providing Industry-Leading Lubricity and Durability to a Broader Range of Complex Device Applications

Oct 10, 2023, 7:30 AM EDT - 2 years ago

Surmodics to Report Fourth Quarter and Fiscal 2023 Financial Results on November 8

Aug 9, 2023, 5:05 PM EDT - 2 years ago

Surmodics to Participate in Upcoming Investor Conferences in August

Aug 6, 2023, 9:00 AM EDT - 2 years ago

Surmodics, Inc. (SRDX) Q3 2023 Earnings Call Transcript

Aug 2, 2023, 7:31 AM EDT - 2 years ago

Surmodics Reports Third Quarter of Fiscal Year 2023 Financial Results; Updates Fiscal Year 2023 Financial Guidance

Jul 12, 2023, 7:30 AM EDT - 2 years ago

Surmodics to Report Third Quarter of Fiscal 2023 Financial Results on August 2

TwongStocks Nov. 18 at 7:16 PM

0 · Reply

SweepCastApp Nov. 18 at 12:28 AM

$SRDX: Unusual Options Activity Alerted CALL flow observed 93x contracts at Strike price of $40 Exp on 11/21/2025 with Premium of $27K and showing BEARISH Sentiment

0 · Reply

AStrokeOfLuck Nov. 17 at 2:25 PM

$SRDX

0 · Reply

OpenOutcrier Nov. 17 at 1:22 PM

$SRDX (+3.0% pre) Surmodics expects to close GTCR acquisition after FTC drops appeal https://ooc.bz/l/84749

0 · Reply

PickAlpha Nov. 17 at 12:55 PM

2/3: Surmodics says FTC drops appeal of court loss, clearing path for $627M sale to GTCR $SRDX $IHI $XLV

0 · Reply

JarvisFlow Nov. 14 at 6:08 PM

Barrington Research updates rating for Surmodics ( $SRDX ) to Underperform.

0 · Reply

Fugazi_ Nov. 12 at 7:46 PM

$SRDX was this court decision planned to be announced the 10th or was it random?

1 · Reply

Estimize Nov. 12 at 11:00 AM

Wall St is expecting -0.13 EPS for $SRDX Q1 [Reporting 02/10 BMO] http://www.estimize.com/intro/srdx?chart=historical&metric_name=eps&utm_c

0 · Reply

basereport Nov. 12 at 2:12 AM

🚀 Strongest stocks of the day Start tracking these today using our free stock screener: https://base.report/screener?filter_key=IJQVaoxW $MSPR $SRDX $ENGN $PUBM

0 · Reply

jerrymaltz Nov. 12 at 1:32 AM

$CJJD $SRDX Bears are retreating, and bulls are pressing their advantage. https://stocktwits.com/jerrymaltz

0 · Reply

Swing_Tradr Nov. 11 at 11:03 PM

Today’s Biggest Winners 🚀 $LFS: +576.79% $MSPR: +75.65% $RDGT: +73.81% $SRDX: +49.72% $ENGN: +46.76%

0 · Reply

topstockalerts Nov. 11 at 10:54 PM

Top Gainers $LFS $MSPR $RDGT $SRDX $ENGN

0 · Reply

Stripette Nov. 11 at 10:21 PM

$SRDX so when is this acquisition supposed to take place?

0 · Reply

RunnerSignals Nov. 11 at 9:23 PM

Top Movers and Shakers in Trading Today $SRDX $ENGN $QNRX flying high while $OM.X $CHGG battle their demons. Who got the juice for tomorrow? Full breakdown inside https://stocksrunner.com/news/2025-11-11-top-movers-and-shakers-in-trading-today

0 · Reply

topstockalerts Nov. 11 at 9:14 PM

Top Gainers $LFS $RDGT $MSPR $SRDX $ENGN

0 · Reply

topstockalerts Nov. 11 at 8:01 PM

Top Gainers $MSPR $GLTO $LFS $ENGN $SRDX

1 · Reply

YGLD Nov. 11 at 7:12 PM

$GLTO She’s Baaaaaccccckkkkkkk 🚨 And Halted Too 🥰 If It Wasn’t For The Price Alert Set Yesterday I Would Have No Knowledge Of This Move… Use Your Tools 🛠️ $MSPR $LFS $SRDX $SPY

0 · Reply

Laurapicksright Nov. 11 at 6:32 PM

$RXRX let’s see that news AH massive push upwards here gap over $6 here 😍😍😍 Watching $MSPR $ENGN $SRDX

2 · Reply

topstockalerts Nov. 11 at 6:24 PM

Top Gainers $MSPR $ENGN $SRDX $PUBM $REAL

0 · Reply

MaverikIT Nov. 11 at 5:44 PM

$SRDX +13.67

0 · Reply

TheRealShortSqueezy Nov. 11 at 5:37 PM

🚨 There are always setups, even in a slow market 📊 Why $MSPR was on watch: -Lots of volume from yesterday’s afterhours action -Known runner ($0.21 → $1.10 last week) -Low float -Lots of dilution possible (good only for a quick scalp) 🔍 What to look for: -Formation of a bullish pennant with increasing volume into the open -Candle close above the upside pennant resistance -Retest and rejection of that prior resistance -Breakout over high of day -Take profits from High of day to previous chart resistance levels. Potential return : 0.62$ to 0.76$ (23%) 🎯 Other potential technical opportunities on : $ENGN $SRDX $PUBM $REAL

0 · Reply

Mikey6028 Nov. 11 at 5:20 PM

$TNGX UP 6% FROM BELL AND OVER 9% FROM PRE MARKET. THIS IS GOING TO GIVE MORE TODAY. HANG ON FOR THE RIDE! $MSRP $ENGN $SRDX $XBIT $PUBM

0 · Reply

Market Cap	614.53M
Revenue (ttm)	126.08M
Net Income (ttm)	-11.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-9.15%
Debt to Equity Ratio	0.27

Volume	5,342,600
Avg Vol	482,120
Day's Range	N/A - N/A
Shares Out	14.30M
Stochastic %K	100%
Beta	1.30
Analysts	Hold
Price Target	$43.00